| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |